Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings)

Nevrologiâ, Nejropsihiatriâ, Psihosomatika

N. V. Vakhnina¹  V. V. Zakharov²  I. N. Samartsev²  V. A. Parfenov²  R. G. Esin³  O. V. Lagoda⁴  S. A. Zhivolupov⁵  L. A. Belova⁶ 

[1] Kazan (Volga) Federal University;I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia;Kazan State Medical Academy, Branch, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia;Neurology Research Center;S.M. Kirov Military Medical Academy, Ministry of Defense of Russia;Ulyanovsk State University;

关键词: chronic cerebral ischemia;    dyscirculatory encephalopathy;    vascular cognitive impairment;    dizziness;    dysphagia;    vinpocetine;   

DOI  :  10.14412/2074-2711-2018-4-139-145

来源: DOAJ

【 摘 要 】

The paper presents the proceedings of the Round Table with the participation of leading neurologists, which is devoted to chronic cerebrovascular diseases. It is noted that chronic cerebral ischemia (CCI), or dyscirculatory encephalopathy (DEP), is one of the most common neurological diagnoses in our country. The pathogenesis, clinical presentations, diagnosis and treatment of CCI (DEP) and its matching with vascular cognitive impairment (CI), which is regarded in foreign literature as the main manifestation of chronic cerebrovascular disease (CVD) were considered. The authors analyze clinical trials evaluating the efficacy of vinpocetine (Cavinton) in chronic CVD, dizziness, CI, as well as the use of new vinpocetine formulations, such as Cavinton Comforte, in various neurological diseases, dysphagia in particular, in poststroke patients.

【 授权许可】

Unknown